Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cizzle Biotech (CIZ) Share Price

Price 1.60p on 05-12-2025 at 19:40:05
Change 0.00p 0%
Buy 1.70p
Sell 1.50p
Last Trade: Buy 616.00 at 1.70p
Day's Volume: 6,513
Last Close: 1.60p
Open: 1.60p
ISIN: GB00BNG2VN02
Day's Range 1.60p - 1.60p
52wk Range: 1.25p - 2.65p
Market Capitalisation: £6.34m
VWAP: 1.680808p
Shares in Issue: 396.39m

Cizzle Biotech (CIZ) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 616 1.70p Ordinary
15:27:55 - 05-Dec-25
Buy* 19 1.70p Ordinary
15:27:01 - 05-Dec-25
Buy* 878 1.70p Ordinary
11:18:39 - 05-Dec-25
Sell* 220,562 1.5101p Ordinary
11:58:25 - 04-Dec-25
Sell* 195,890 1.533p Ordinary
11:57:52 - 04-Dec-25
Buy* 105,717 1.70p Ordinary
10:27:00 - 04-Dec-25
Buy* 2,000 1.685p Ordinary
09:15:49 - 04-Dec-25
Sell* 49,312 1.533p Ordinary
09:13:14 - 04-Dec-25
Sell* 49,312 1.533p Ordinary
09:10:55 - 04-Dec-25
Buy* 29 1.70p Ordinary
14:24:24 - 03-Dec-25
See more Cizzle Biotech trades

Cizzle Biotech (CIZ) Share Price History

Time period:
to
Date Open High Low Close Volume
5th Dec 2025 (Fri) 1.60 1.60 1.60 1.60 6,513
4th Dec 2025 (Thu) 1.60 1.60 1.60 1.60 622,793
3rd Dec 2025 (Wed) 1.55 1.60 1.55 1.60 475,302
2nd Dec 2025 (Tue) 1.65 1.65 1.55 1.55 282,565
1st Dec 2025 (Mon) 1.65 1.65 1.65 1.65 100,719
28th Nov 2025 (Fri) 1.65 1.65 1.65 1.65 62,073
27th Nov 2025 (Thu) 1.65 1.65 1.65 1.65 28,762
26th Nov 2025 (Wed) 1.65 1.65 1.65 1.65 550,865
25th Nov 2025 (Tue) 1.65 1.65 1.65 1.65 265,932
24th Nov 2025 (Mon) 1.65 1.65 1.65 1.65 1,018,978
21st Nov 2025 (Fri) 1.65 1.65 1.65 1.65 234,364
20th Nov 2025 (Thu) 1.70 1.70 1.65 1.65 201,025
19th Nov 2025 (Wed) 1.70 1.70 1.70 1.70 133,149
18th Nov 2025 (Tue) 1.65 1.70 1.65 1.70 473,571
17th Nov 2025 (Mon) 1.80 1.80 1.65 1.65 1,097,659
14th Nov 2025 (Fri) 1.80 1.80 1.80 1.80 268,211
13th Nov 2025 (Thu) 1.95 1.95 1.80 1.80 861,719
12th Nov 2025 (Wed) 1.95 1.95 1.90 1.95 715,317
11th Nov 2025 (Tue) 1.90 1.95 1.90 1.95 1,546,181
10th Nov 2025 (Mon) 1.75 1.90 1.65 1.90 2,074,279
7th Nov 2025 (Fri) 1.75 1.75 1.75 1.75 424,589
See more Cizzle Biotech price history

Cizzle Biotech (CIZ) Regulatory News

Date Source Headline
5th Nov 2025 7:01 am RNS £250,000 Convertible Loan Note Issue
5th Nov 2025 7:00 am RNS LOI with leading UK Clinical Diagnostic Group
27th Oct 2025 11:32 am RNS Change of Registered Office
30th Sep 2025 7:00 am RNS Interim Results
29th Sep 2025 7:00 am RNS Update on Clinical Laboratory Partnerships in USA
18th Aug 2025 7:00 am RNS Commercial Progress in USA
30th Jun 2025 1:45 pm RNS Result of AGM
6th Jun 2025 11:00 am RNS Notice of AGM
28th May 2025 7:00 am RNS Holding(s) in Company
20th May 2025 7:00 am RNS £150,000 Convertible Loan Note Issue
See more Cizzle Biotech regulatory news

Cizzle Biotech (CIZ) Share News

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract

18th Aug 2025 22:11

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds

20th May 2025 21:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Cizzle Biotechnology appoints Founder Dawn Coverley as CSO

2nd Jan 2025 14:29

Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Appoints Founder & Non-Executive Director Dawn Coverley as chief scientific officer, effective immediately. Says the new role replaces her position as a NED and accelerates its global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025. Read More

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

30th Sep 2024 18:37

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

See more Cizzle Biotech news
FTSE 100 Latest
Value9,667.01
Change-43.86

Login to your account

Forgot Password?

Not Registered